XML 57 R46.htm IDEA: XBRL DOCUMENT v3.25.3
SEGMENT REPORTING (Details)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2025
USD ($)
segment
Jun. 30, 2025
USD ($)
Mar. 31, 2025
USD ($)
Sep. 30, 2024
USD ($)
Jun. 30, 2024
USD ($)
Mar. 31, 2024
USD ($)
Sep. 30, 2025
USD ($)
segment
Sep. 30, 2024
USD ($)
Segment Reporting [Abstract]                
Number of operating segments | segment 1           1  
Number of reportable segments | segment 1           1  
Revenues:                
Total revenues $ 47,227     $ 28,271     $ 135,866 $ 29,457
Costs and operating expenses:                
Cost of goods sold 1,043     456     3,439 473
Research and development                
Research and development 21,070     20,153     57,884 80,305
Selling, general and administrative                
Commercial expenses 39,001     35,877     117,588 102,361
Total costs and operating expenses 61,114     56,486     178,911 183,139
Loss from operations (13,887)     (28,215)     (43,045) (153,682)
Net loss (18,428) $ (16,375) $ (19,835) (26,447) $ (67,383) $ (55,390) (54,638) (149,220)
Product revenue, net                
Revenues:                
Total revenues 47,167     28,209     135,610 28,989
Royalties                
Revenues:                
Total revenues 60     62     256 468
Reportable Segment                
Revenues:                
Total revenues 47,300     28,300     135,900 29,500
Costs and operating expenses:                
Cost of goods sold 1,000     500     3,400 500
Selling, general and administrative                
Other segment expenses 20,400     18,400     62,600 52,300
Total costs and operating expenses 61,100     56,500     178,900 183,100
Loss from operations (13,900)     (28,200)     (43,000) (153,700)
Total interest and other income (expense) (4,500)     1,800     (11,600) 4,500
Net loss (18,400)     (26,400)     (54,600) (149,200)
Reportable Segment | Product revenue, net                
Revenues:                
Total revenues 47,200     28,200     135,600 29,000
Reportable Segment | Royalties                
Revenues:                
Total revenues 100     100     300 500
Reportable Segment | Research and clinical expenses                
Research and development                
Research and development 18,000     17,900     51,500 55,000
Reportable Segment | Chemistry, manufacturing, and control expenses                
Research and development                
Research and development 3,100     2,300     6,400 25,300
Reportable Segment | Commercial expenses                
Selling, general and administrative                
Commercial expenses $ 18,600     $ 17,400     $ 55,000 $ 50,000